Clinical Investigation of the SelectSecure Pacing Lead
1 other identifier
interventional
365
3 countries
31
Brief Summary
People who have a slow heart beat, or whose heart does not beat on its own, may be in need of an electronic device called a pacemaker. A pacemaker is implanted surgically just under the skin in the upper chest area. This device helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The purpose of this study is to demonstrate that the SelectSecure (Model 3830) lead is safe and effective for both sensing the heart's natural rhythm and pacing the heart when it does not beat on its own. This lead will be studied in both the right atrium and right ventricle. A previously market approved Medtronic lead model will serve as a comparison to prove the safety and effectiveness of the SelectSecure Model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2002
Typical duration for not_applicable
31 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 16, 2005
CompletedFirst Posted
Study publicly available on registry
December 19, 2005
CompletedOctober 13, 2006
October 1, 2006
December 16, 2005
October 11, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives
Secondary Outcomes (1)
Lead and catheter handling characteristics, and lead impedance
Interventions
Eligibility Criteria
You may qualify if:
- Subjects who are in need of a pacemaker that paces in both the right atrium and ventricle.
You may not qualify if:
- Subjects who are in need of an implantable cardioverter defibrillator (ICD).
- Subjects who have a mechanical or diseased tricuspid valve (a structure in the heart, located between the right atrium and right ventricle, which allows blood to flow from the atrium to the ventricle).
- Steroid contraindication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (31)
Unknown Facility
Anchorage, Alaska, United States
Unknown Facility
Peoria, Arizona, United States
Unknown Facility
Long Beach, California, United States
Unknown Facility
Santa Rosa, California, United States
Unknown Facility
Fort Lauderdale, Florida, United States
Unknown Facility
Evanston, Illinois, United States
Unknown Facility
Indianapolis, Indiana, United States
Unknown Facility
Des Moines, Iowa, United States
Unknown Facility
Iowa City, Iowa, United States
Unknown Facility
Kansas City, Kansas, United States
Unknown Facility
Boston, Massachusetts, United States
Unknown Facility
Detroit, Michigan, United States
Unknown Facility
Robbinsdale, Minnesota, United States
Unknown Facility
Saint Paul, Minnesota, United States
Unknown Facility
Kansas City, Missouri, United States
Unknown Facility
Springfield, Missouri, United States
Unknown Facility
Livingston, New Jersey, United States
Unknown Facility
Winston-Salem, North Carolina, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Lancaster, Pennsylvania, United States
Unknown Facility
Sayre, Pennsylvania, United States
Unknown Facility
Germantown, Tennessee, United States
Unknown Facility
Nashville, Tennessee, United States
Unknown Facility
Austin, Texas, United States
Unknown Facility
Temple, Texas, United States
Unknown Facility
Richmond, Virginia, United States
Unknown Facility
Melbourne, Australia
Unknown Facility
Kingston, Canada
Unknown Facility
London, Canada
Unknown Facility
Ottawa, Canada
Unknown Facility
Sainte-Foy, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 16, 2005
First Posted
December 19, 2005
Study Start
August 1, 2002
Study Completion
August 1, 2005
Last Updated
October 13, 2006
Record last verified: 2006-10